Janux Therapeutics JANX Net Change in Cash
Net Change in Cash at other companies
Other financials
Where this comes from
Reported directly by Janux Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect.
The official record: Janux Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Janux Therapeutics's net change in cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Janux Therapeutics's net change in cash?
- Janux Therapeutics (JANX) reported net change in cash of -$506K in Q1 2026.
- How has Janux Therapeutics's net change in cash changed year-over-year?
- Janux Therapeutics's net change in cash increased by 99.9% year-over-year, from -$356.86M to -$506K.
- What does net change in cash mean?
- Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.